Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
Yap/Taz regulate alveolar regeneration and resolution of lung inflammation
Ryan LaCanna, … , Marla R. Wolfson, Ying Tian
Ryan LaCanna, … , Marla R. Wolfson, Ying Tian
Published May 1, 2019; First published April 15, 2019
Citation Information: J Clin Invest. 2019;129(5):2107-2122. https://doi.org/10.1172/JCI125014.
View: Text | PDF
Categories: Research Article Pulmonology Stem cells

Yap/Taz regulate alveolar regeneration and resolution of lung inflammation

  • Text
  • PDF
Abstract

Alveolar epithelium plays a pivotal role in protecting the lungs from inhaled infectious agents. Therefore, the regenerative capacity of the alveolar epithelium is critical for recovery from these insults in order to rebuild the epithelial barrier and restore pulmonary functions. Here, we show that sublethal infection of mice with Streptococcus pneumoniae, the most common pathogen of community-acquired pneumonia, led to exclusive damage in lung alveoli, followed by alveolar epithelial regeneration and resolution of lung inflammation. We show that surfactant protein C–expressing (SPC-expressing) alveolar epithelial type II cells (AECIIs) underwent proliferation and differentiation after infection, which contributed to the newly formed alveolar epithelium. This increase in AECII activities was correlated with increased nuclear expression of Yap and Taz, the mediators of the Hippo pathway. Mice that lacked Yap/Taz in AECIIs exhibited prolonged inflammatory responses in the lung and were delayed in alveolar epithelial regeneration during bacterial pneumonia. This impaired alveolar epithelial regeneration was paralleled by a failure to upregulate IκBa, the molecule that terminates NF-κB–mediated inflammatory responses. These results demonstrate that signals governing resolution of lung inflammation were altered in Yap/Taz mutant mice, which prevented the development of a proper regenerative niche, delaying repair and regeneration of alveolar epithelium during bacterial pneumonia.

Authors

Ryan LaCanna, Daniela Liccardo, Peggy Zhang, Lauren Tragesser, Yan Wang, Tongtong Cao, Harold A. Chapman, Edward E. Morrisey, Hao Shen, Walter J. Koch, Beata Kosmider, Marla R. Wolfson, Ying Tian

×

Figure 5

Inflammatory responses in Yap/Taz mutant lungs.

Options: View larger image (or click on image) Download as PowerPoint
Inflammatory responses in Yap/Taz mutant lungs.
(A) GFP+ AECIIs at 7 dpi...
(A) GFP+ AECIIs at 7 dpi were sorted by FACS and analyzed by qRT-PCR (n = 4 per group). (B) BALF was analyzed for IL-1b by ELISA assay (n = 4–6 per group). (C) Cytokine assay showed protein levels of IL-1b and CXCL9 in mouse lung lysates (n = 1 per group). (D) Flow cytometry of dissociated lung cells was performed by gating on CD3+CD45+ cells, and quantification of total number of CD3+CD45+ cells in the lung was graphed (n = 3–10 per group). (E) Confocal images of lung sections at 14 dpi with nuclei labeled by DAPI (blue) and antibodies to GFP (green) and CD3 (red). Scale bars: 20 μm. (F) Quantification of the number of CD3+ cells as the ratio of CD3+ cell number versus GFP+ area per field using ImageJ (n = 3–5 per group). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, Student’s t test (A) and 2-way ANOVA (B, D, F).
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts